PH26019A - Use of TP-receptor antagonists to modify the action of myofibrolasts - Google Patents

Use of TP-receptor antagonists to modify the action of myofibrolasts Download PDF

Info

Publication number
PH26019A
PH26019A PH38487A PH38487A PH26019A PH 26019 A PH26019 A PH 26019A PH 38487 A PH38487 A PH 38487A PH 38487 A PH38487 A PH 38487A PH 26019 A PH26019 A PH 26019A
Authority
PH
Philippines
Prior art keywords
compound
receptor antagonist
solution
thromboxane
hydrochloride salt
Prior art date
Application number
PH38487A
Other languages
English (en)
Inventor
Ian Leslie Naylor
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PH26019A publication Critical patent/PH26019A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
PH38487A 1988-04-12 1989-04-12 Use of TP-receptor antagonists to modify the action of myofibrolasts PH26019A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888808599A GB8808599D0 (en) 1988-04-12 1988-04-12 Medicaments

Publications (1)

Publication Number Publication Date
PH26019A true PH26019A (en) 1992-01-29

Family

ID=10635039

Family Applications (1)

Application Number Title Priority Date Filing Date
PH38487A PH26019A (en) 1988-04-12 1989-04-12 Use of TP-receptor antagonists to modify the action of myofibrolasts

Country Status (9)

Country Link
EP (1) EP0337739A3 (fr)
JP (1) JPH0228120A (fr)
KR (1) KR890015743A (fr)
AU (1) AU621598B2 (fr)
DK (1) DK173789A (fr)
GB (1) GB8808599D0 (fr)
IL (1) IL89910A0 (fr)
PH (1) PH26019A (fr)
ZA (1) ZA892672B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2354708B (en) * 1999-10-01 2004-06-02 Johnson & Johnson Medical Ltd Compositions for the treatment of wound contracture
JP4686472B2 (ja) 2004-10-26 2011-05-25 京セラ株式会社 弾性表面波素子及び通信装置
EP2150111B1 (fr) 2007-01-18 2016-10-19 Evolva SA 1,3-dioxanes substitués utilisés en tant que modulateurs ppar
MX2009007667A (es) 2007-01-18 2011-12-08 Evolva Sa Profarmacos de 1,3-dioxanos sustituidos y sus usos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2127406B (en) * 1982-09-16 1986-03-05 Glaxo Group Ltd Piperidinlycyclopentanolheptenoic acid salt

Also Published As

Publication number Publication date
ZA892672B (en) 1990-04-25
GB8808599D0 (en) 1988-05-11
AU621598B2 (en) 1992-03-19
EP0337739A2 (fr) 1989-10-18
KR890015743A (ko) 1989-11-25
DK173789D0 (da) 1989-04-11
AU3275489A (en) 1989-10-19
IL89910A0 (en) 1989-12-15
JPH0228120A (ja) 1990-01-30
EP0337739A3 (fr) 1990-10-10
DK173789A (da) 1989-10-13

Similar Documents

Publication Publication Date Title
US11505537B2 (en) Compositions comprising methylphenidate-prodrugs, processes of making and using the same
US20080108589A1 (en) Method of treatment with coadministration of aspirin and prasugrel
ES2781681T3 (es) Profármacos de ésteres de [3-(1-(1H-imidazol-4-il)etil)-2-metilfenil]-metanol para reducir la presión intraocular
US20040152745A1 (en) Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors
US20110098284A1 (en) Methods and compositions for treating pain
EP2501381B1 (fr) Traitement de la fibrillation atriale
US8637566B2 (en) Slow infusion of sulcardine and its salts
KR20010021854A (ko) 말초 작용성 항소양성 아편제
JP2024091930A (ja) ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
AU621598B2 (en) Improvements in or relating to pharmaceutical compounds and compositions
WO2018107131A1 (fr) Promédicaments méthylphénidates, procédés de fabrication et utilisation associés
AU2018390274C1 (en) Therapeutic agent for glaucoma comprising FP agonist and β blocker
SK282353B6 (sk) Farmaceutický prostriedok na intravenózne podanie
HK1254495B (en) Use of sulcardine for the treatment of atrial fibrillation
US20040006142A1 (en) Ocular tension depressor
HK1176859B (en) Treatment of atrial fibrillation
HK1176859A (en) Treatment of atrial fibrillation
WO1993012794A1 (fr) Utilisation d'un derive de l'animazoline pour le traitement du glaucome